Vanguard Group Inc Alkermes Plc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Vanguard Group Inc holds 18,496,185 shares of ALKS stock, worth $611 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,496,185
Previous 18,971,637
2.51%
Holding current value
$611 Million
Previous $531 Million
0.18%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$961 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$405 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$291 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$250 Million3.55% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.48MShares$181 Million0.25% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.42B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...